Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection [Phase 2]

View source ↗

Summary

Phase 2 trial investigating high-strength cranberry supplementation for prevention of recurrent urinary tract infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High Strength Cranberry Supplementation

Snippet

Sponsor: Swisse Wellness Pty Ltd | Conditions: Urinary Tract Infection | Phase 2 | Status: COMPLETED